Toward Molecular Imaging-Driven Drug Development in Oncology

Elisabeth G. E. de Vries; T. H.  Oude Munnink; Marcel A. T. M. van Vugt; Wouter B. Nagengast

doi:10.1158/2159-8274.CD-11-0051

Toward Molecular Imaging-Driven Drug Development in Oncology

Elisabeth G. E. de Vries^*, T. H. Oude Munnink, Marcel A. T. M. van Vugt, Wouter B. Nagengast

^*Corresponding author voor dit werk

Onderzoeksoutput › peer review

22 Citaten (Scopus)

13 Downloads (Pure)

Samenvatting

With current testing strategies, the number of novel targeted anticancer agents will exceed our drug selection capacity. Molecular imaging is a powerful additional tool that can assist us in selecting effective drugs and help patients benefit from targeted agents. Moreover, measurement of the functional effects of such targeted agents could permit dynamic tuning of treatment selection at the earliest time point at which loss of functional effects is observed. Cancer Discovery; 1(1); 25-8. (C) 2011 AACR.

Originele taal-2	English
Pagina's (van-tot)	25-28
Aantal pagina's	4
Tijdschrift	Cancer Discovery
Volume	1
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.1158/2159-8274.CD-11-0051
Status	Published - jun.-2011

Toegang tot document

10.1158/2159-8274.CD-11-0051

Toward Molecular Imaging–Driven Drug Development in Oncology Final publisher's version, 2,83 MBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

@article{f9c946f29b01430d8be78b0e9bc08305,

title = "Toward Molecular Imaging-Driven Drug Development in Oncology",

abstract = "With current testing strategies, the number of novel targeted anticancer agents will exceed our drug selection capacity. Molecular imaging is a powerful additional tool that can assist us in selecting effective drugs and help patients benefit from targeted agents. Moreover, measurement of the functional effects of such targeted agents could permit dynamic tuning of treatment selection at the earliest time point at which loss of functional effects is observed. Cancer Discovery; 1(1); 25-8. (C) 2011 AACR.",

keywords = "METASTATIC BREAST-CANCER, TOMOGRAPHIC ASSESSMENT, PROSTATE-CANCER",

author = "{de Vries}, {Elisabeth G. E.} and {Oude Munnink}, {T. H.} and {van Vugt}, {Marcel A. T. M.} and Nagengast, {Wouter B.}",

year = "2011",

month = jun,

doi = "10.1158/2159-8274.CD-11-0051",

language = "English",

volume = "1",

pages = "25--28",

journal = "Cancer Discovery",

issn = "2159-8274",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

TY - JOUR

T1 - Toward Molecular Imaging-Driven Drug Development in Oncology

AU - de Vries, Elisabeth G. E.

AU - Oude Munnink, T. H.

AU - van Vugt, Marcel A. T. M.

AU - Nagengast, Wouter B.

PY - 2011/6

Y1 - 2011/6

N2 - With current testing strategies, the number of novel targeted anticancer agents will exceed our drug selection capacity. Molecular imaging is a powerful additional tool that can assist us in selecting effective drugs and help patients benefit from targeted agents. Moreover, measurement of the functional effects of such targeted agents could permit dynamic tuning of treatment selection at the earliest time point at which loss of functional effects is observed. Cancer Discovery; 1(1); 25-8. (C) 2011 AACR.

AB - With current testing strategies, the number of novel targeted anticancer agents will exceed our drug selection capacity. Molecular imaging is a powerful additional tool that can assist us in selecting effective drugs and help patients benefit from targeted agents. Moreover, measurement of the functional effects of such targeted agents could permit dynamic tuning of treatment selection at the earliest time point at which loss of functional effects is observed. Cancer Discovery; 1(1); 25-8. (C) 2011 AACR.

KW - METASTATIC BREAST-CANCER

KW - TOMOGRAPHIC ASSESSMENT

KW - PROSTATE-CANCER

U2 - 10.1158/2159-8274.CD-11-0051

DO - 10.1158/2159-8274.CD-11-0051

M3 - Review article

SN - 2159-8274

VL - 1

SP - 25

EP - 28

JO - Cancer Discovery

JF - Cancer Discovery

IS - 1

ER -

Toward Molecular Imaging-Driven Drug Development in Oncology

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit